Mosley Selected for Clinical and Translational Science Career Mentoring Program

Scott Mosley, PharmD, is one of four USC faculty members accepted into the university’s prestigious Mentored Career Development in Clinical and Translational Science (MCD-CTS) Training Program. (Photo by Isaac Mora)

Scott Mosley, PharmD, an assistant professor of clinical pharmacy at the USC School of Pharmacy, is one of four USC faculty members accepted into the university’s prestigious Mentored Career Development in Clinical and Translational Science (MCD-CTS) Training Program for the three-year period June 1, 2019-May 31, 2022.

The Mentored Career Development in Clinical and Translational Science (MCD-CTS) is a three-year program created to support research career development for health professionals or individuals with research doctoral degrees who wish to pursue formal training and a career in clinical and translational research.

Mosley, whose research is focused in pharmacogenomics implementation, joined the faculty in June 2018 after completing a postdoctoral research fellowship at the University of Florida College of Pharmacy in the Center for Pharmacogenomics.

The program, funded by the National Institutes of Health (NIH), provides scholars with an opportunity to acquire and refine the core knowledge and skill sets needed to become future clinical translational investigators, and be taught the skills to complete a grant that would have a high probability of being funded.

“I’m excited and inspired to embark on this opportunity and I’m looking forward to helping patients in a variety of therapeutic areas through our research efforts,” Mosley says.

In June 2019, Mosley will partner with Keck School of Medicine and LAC+USC Medical Center to start a one-year study following approximately 200 patients from diverse communities in Los Angeles after heart attack. Patients participating in the research study will undergo tailored drug therapy for one year following a genotype test. “It’s a high-impact clinical situation,” he says.

“Dr. Mosley is a rising clinical scientist whose research in pharmacogenomics will benefit the care of our diverse patients and training of our students,” says Paul Beringer, chair of the Titus Department of Clinical Pharmacy. “This three-year award is validation of his potential as a clinical scholar.”

The other awardees are Julie Jaffray, pediatric oncologist from Keck School of Medicine, Natalia Sanchez, coagulation expert from the Ostrow School of Dentistry, and Jeremy Mason, bioengineer from Keck School of Medicine’s Department of Urology.